Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
01/30/2014 | WO2014017471A1 Melamine analyzing nucleic acid sensor, analyzing device, and analysis method |
01/30/2014 | WO2014017462A1 Pharmaceutical composition for inhibiting abnormal spine formation |
01/30/2014 | WO2014017390A1 Nad-dependent glucose dehydrogenase and production method thereof |
01/30/2014 | WO2014017319A1 Filaggrin production promoter, therapeutic agent for diseases associated with reduction in production of filaggrin, and method for screening for said therapeutic agent |
01/30/2014 | WO2014017193A1 Pre-processing/electrophoresis integrated cartridge, pre-processing integrated capillary electrophoresis device, and pre-processing integrated capillary electrophresis method |
01/30/2014 | WO2014017187A1 Preparation method and preparation device for sample for nucleic acid amplification reaction |
01/30/2014 | WO2014017116A1 Microwell array chip, and method for collecting cells |
01/30/2014 | WO2014017106A1 Compositions Comprising RAC Mutants, and Methods of Use Thereof |
01/30/2014 | WO2014016706A2 Detection of dinoflagellates |
01/30/2014 | WO2014016690A2 Method for detecting or measuring the impact of a viral vector composition on eukaryotic cells and biomarkers used thereof |
01/30/2014 | WO2014016605A1 Assay |
01/30/2014 | WO2014016534A1 Method of detecting oxa-048 carbapenemase producing bacteria |
01/30/2014 | WO2014016436A1 Methods for predicting whether a subject is at risk of developing a follicular lymphoma |
01/30/2014 | WO2014016202A1 Methods for catalytic alkylation of nucleic acids |
01/30/2014 | WO2014015925A1 Method for differentiating between living and dead cells |
01/30/2014 | WO2014015824A1 Method for screening micrornas with gene silencing function at both levels of transcription and post-transcription |
01/30/2014 | WO2014015706A1 Method for nondestructive detection of mirna expression in cell and determination of cell type and state |
01/30/2014 | WO2013185029A3 The use of endotoxin neutralization as a biomarker for intestinal wall damage |
01/30/2014 | WO2013181125A3 Methods of detecting single nucleotide polymorphisms at codon 600 of human braf |
01/30/2014 | WO2013177206A3 Single-particle analysis of particle populations |
01/30/2014 | WO2013168162A4 Clustered single nucleotide polymorphisms in the human acetylcholinesterase gene and uses thereof in diagnosis and therapy |
01/30/2014 | WO2013150167A3 Micro-rna expression model as an indicator of survival of patients affected by metastatic colorectal cancer |
01/30/2014 | WO2012177640A8 Modulation of tissue transglutaminase activation in disease |
01/30/2014 | US20140033370 Visual screening for enzymes on the phenylpropanoid pathway |
01/30/2014 | US20140033359 Lettuce variety 45-03 rz |
01/30/2014 | US20140033358 Hybrid pepper varieties 35-170 rz and/or 35-171 rz |
01/30/2014 | US20140033337 Methods of Modifying Eukaryotic Cells |
01/30/2014 | US20140033336 Methods of Modifying Eukaryotic Cells |
01/30/2014 | US20140031521 Plant myb transcription factor homologs |
01/30/2014 | US20140031411 Gpnmb/osteoactivin as a biomarker and drug target in cardiac diseases |
01/30/2014 | US20140031389 Screening methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases |
01/30/2014 | US20140031327 Non-surgical method of treatment for cataract |
01/30/2014 | US20140031292 Yeast Cell Surface Display of Proteins and Uses Thereof |
01/30/2014 | US20140031291 Pp2a regulatory subunit modification in disease |
01/30/2014 | US20140031260 Molecular Diagnostic Test for Cancer |
01/30/2014 | US20140031259 Biomarkers for predicting sensitivity to cancer treatments |
01/30/2014 | US20140031258 Serum-based mirna microarray and its use in diagnosis and treatment of barrett's esophagus (be) and esophageal adenocarcinoma (eac) |
01/30/2014 | US20140031257 Methods and biomarkers for detection of gastrointestinal cancers |
01/30/2014 | US20140031255 Method for identifying neonates at risk for necrotizing enterocolitis |
01/30/2014 | US20140031254 Detection of chromosomal abnormalities associated with endometrial cancer |
01/30/2014 | US20140031252 Compositions and methods for the diagnosis and treatment of inlammatory disorders and fibrotic disease |
01/30/2014 | US20140031251 Methods of classifying human subjects with regard to cancer prognosis |
01/30/2014 | US20140031250 Biomarkers of Cancer |
01/30/2014 | US20140031248 Detection of Amplification Products |
01/30/2014 | US20140031246 Circulating micrornas are biomarkers of various diseases |
01/30/2014 | US20140031244 Optimized probe selection method |
01/30/2014 | US20140031243 Multiplex detection of molecular species in cells by super-resolution imaging and combinatorial labeling |
01/30/2014 | US20140031242 Method for discovering pharmacogenomic biomarkers |
01/30/2014 | US20140031241 Paired end bead amplification and high throughput sequencing |
01/30/2014 | US20140031240 Tm-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection |
01/30/2014 | US20140031239 Method of sequencing |
01/30/2014 | US20140031238 Alternative nucleotide flows in sequencing-by-synthesis methods |
01/30/2014 | US20140031237 Methods of enriching for and identifying polymorphisms |
01/30/2014 | US20140030803 Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivatives |
01/30/2014 | US20140030799 Apparatus for detecting tumor cells |
01/30/2014 | US20140030798 Processing polynucleotide-containing samples |
01/30/2014 | US20140030765 Modified dna polymerases for improved amplification |
01/30/2014 | US20140030750 High Throughput In Vitro Translation (Cell-Lysate Based) Assay for Detecting Quorum Sensing Signals |
01/30/2014 | US20140030749 Modified glucose dehydrogenase |
01/30/2014 | US20140030746 Kinase substrate sensor |
01/30/2014 | US20140030740 Rapid Bioluminescence Detection System |
01/30/2014 | US20140030730 Acetyl-coa producing enzymes in yeast |
01/30/2014 | US20140030726 Methods for identifying modulators of murine double minute 2 |
01/30/2014 | US20140030725 Mutant protease biosensors with enhanced detection characteristics |
01/30/2014 | US20140030723 Method for Predicting the Response to a Therapy |
01/30/2014 | US20140030722 Nlrp7-based diagnosis of female reproductive conditions |
01/30/2014 | US20140030721 Exonuclease Enabled Proximity Extension Assays |
01/30/2014 | US20140030720 Dual reference calibration method and system for quantifying polynucleotides |
01/30/2014 | US20140030719 Method for enhancing efficiency and sensitivity in nucleic acid amplification from biological materials using ionic liquids |
01/30/2014 | US20140030715 Method of using both mir-196a and mir-196b as biomarkers for detecting oral cancer |
01/30/2014 | US20140030714 Method and means for distinguishing malignant from benign tumor samples, in particular in routine air dried fine needle aspiration biopsy (FNAB) |
01/30/2014 | US20140030713 Filler for ion exchange chromatography and method for separating and detecting nucleic acid strand |
01/30/2014 | US20140030712 Genomic approach to the identification of biomarkers for antibiotic resistance and susceptibility in clinical isolates of bacterial pathogens |
01/30/2014 | US20140030711 Methods and biomarkers for detection of lymphoma |
01/30/2014 | US20140030710 Gardnerella vaginalis assay |
01/30/2014 | US20140030709 Biomarker for Detecting High-Altitude Adaptation and High-Altitude Pulmonary Edema |
01/30/2014 | US20140030708 Translation-coupling systems |
01/30/2014 | US20140030706 Methods of identifying a cellular nascent rna transcript |
01/30/2014 | US20140030703 Compositions and Methods for Detecting and Identifying Nucleic Acid Sequences in Biological Samples |
01/30/2014 | US20140030702 Modified influenza virus for monitoring and improving vaccine efficiency |
01/30/2014 | US20140030701 Compositions, reaction mixtures and methods for detecting nucleic acids from type a1 and/or type c1 human papillomavirus |
01/30/2014 | US20140030699 Electrically conductive polymer electrodes with incorporated viruses |
01/30/2014 | US20140030698 Multiplex assay for the detection of citrus pathogens |
01/30/2014 | US20140030290 Infectious Clones of RNA Viruses and Vaccines and Diagnostic Assays Derived Thereof |
01/30/2014 | US20140030272 Methods for Diagnosing and Treating Iron Dysregulation |
01/30/2014 | US20140030261 Method for prognosticating the clinical response of a patient to b-lymphocyte inhibiting or depleting therapy in interferon-driven diseases such as sle |
01/30/2014 | US20140030257 Agtr1 as a marker for bevacizumab combination therapies |
01/30/2014 | US20140030255 Methods of predicting cancer cell response to therapeutic agents |
01/30/2014 | US20140030219 Methods of diagnosing and treating age-related macular degeneration |
01/30/2014 | US20140027312 System and methods to account for interferents in a glucose biosensor |
01/30/2014 | US20140027310 Electric measurement of monolayers following pro-cleave detection of presence and activity of enzymes and other target analytes |
01/30/2014 | US20140027280 Fad-conjugated glucose dehydrogenase gene |
01/30/2014 | DE102012014922A1 Test- and result releasing method in diagnostic system, comprises processing sample, determining genetic information, and generating diagnostic results |
01/30/2014 | DE10147439B4 Verfahren zur Isolierung von DNA aus biologischen Proben A process for the isolation of DNA from biological samples |
01/29/2014 | EP2690180A1 Method for enhancing efficiency and sensitivity in nucleic acid amplification from biological materials using ionic liquids |
01/29/2014 | EP2690179A1 Compositions for detecting foodstuff spoilage microorganisms |
01/29/2014 | EP2689847A1 Methods for catalytic alkylation of nucleic acids |
01/29/2014 | EP2689038A1 System and method for detection of hiv integrase variants |
01/29/2014 | EP2689037A1 Microbicidal compositions and methods of production use thereof |
01/29/2014 | EP2689035A1 Method and kit for determining in vitro the probability for an individual to suffer from colorectal cancer |